Autopsy report · NCT01860664

Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis

“The Sponsor has stopped responding to calls and emails”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 8 months before it stopped.
• 15 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Koffler Vision Group

Sponsor type

University, hospital or other

Conditions

Allergic Conjunctivitis

Interventions

hydrocortisone ophthalmic ointment 0.5%; placebo

Participants

15

Sites

1

Countries

United States

Trials that died the same way

• Patient Perception of MultiPulse Therapy™ (MPT™)
  “Sponsor ceased operations” (77% match in meaning)
• A Study Evaluating the Onset-of-Action, Safety, and Efficacy of RDX227675 for the Treatment of Hyperkalemia
  “Sponsor stopped program\]” (72% match in meaning)
• Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
  “Sponsor Terminated” (70% match in meaning)
• Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer
  “Sponsor chose not to continue” (69% match in meaning)
• Target Volume Mode Controlled Ventilator in Obesity Hypoventilation Syndrome
  “Stopped by the sponsor” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.